Loading...

RGEN REPLIGEN CORP Management Changes 8-K Filing

RPLG

RGN

REPLIGEN CORP

(RGEN)

2026 8-K

Annual Meeting Results

Quarterly Results

Financial Results Announced

Financial Results Update

Management Change

Financial Statements

Financial Statements

Financial Results

Q3 Financial Results

Financial Restatement

Financial Results Announcement

Unauthorized Access to Info...

Management Change

CEO Transition and Appointm...

Annual Meeting of Shareholders

Financial Results Announcement

Appointment of Margaret A. Pax

Financial Results Announcement

Convertible Senior Notes Is...

Issuance of Convertible Sen...

Financial Results Announcement

Acquisition Announcement

Appointment of CFO

Financial Results Announcement

Annual Meeting Results

Financial Results for Q1 2023

Acquisition of FlexBiosys Inc.

Acquisition Agreement

Financial Results Announcement

Appointment of Martin Madau...

External Links:

On January 6, 2026, Repligen Corp. announced Dr. Martin D. Madaus will become Chair of the Board on March 13, 2026, succeeding Tony J. Hunt who will retire.

AI Assistant

REPLIGEN CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.